Yifan Zhai
Overview
Explore the profile of Yifan Zhai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
62
Citations
528
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li Y, Chen J, Mu X, Wang X, Liu Y, Chen H, et al.
Insect Sci
. 2025 Feb;
PMID: 39963925
The gut microbiota has been linked to the pathophysiology of inflammatory bowel disease (IBD). Current animal models are limited in the generation of germ-free animals to evaluate the roles of...
2.
Wan S, Wang S, Li Y, Xie Y, Li Q, Fang Y, et al.
Ecotoxicol Environ Saf
. 2025 Jan;
290:117777.
PMID: 39854864
With the increasing severity of heavy metal pollution in soil and water, phytoremediation is becoming increasingly popular because of its low cost, high returns, and environmental friendliness. The use of...
3.
Wang C, Yin Z, Wang Y, Liu Y, Zhao S, Dai X, et al.
Insects
. 2025 Jan;
15(12.
PMID: 39769538
is a highly effective natural enemy for controlling thrips, tetranychids, aphids, and various Lepidoptera pests. Nevertheless, the molecular mechanisms underlying its interactions with host pests remain unclear. Screening for optimal...
4.
Jain J, Pham T, Begum S, Romero-Medina M, Bellini N, Li Y, et al.
iScience
. 2025 Jan;
27(12):111470.
PMID: 39758987
Latent viral reservoirs (VRs) represent a main barrier to HIV cure. Thus, developing new approaches that can purge and eliminate VRs paves the path toward achieving an HIV-1 cure. APG-1387,...
5.
Jabbour E, Oehler V, Koller P, Jamy O, Lomaia E, Hunter A, et al.
JAMA Oncol
. 2024 Nov;
11(1):28-35.
PMID: 39570620
Importance: Patients with chronic myeloid leukemia (CML) or Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL) resistant or intolerant to BCR-ABL1 tyrosine kinase inhibitors (TKIs) have limited treatment options. Olverembatinib, which is...
6.
Wang S, Li Q, Li Y, Wan S, Yin Z, Zhao S, et al.
Int J Mol Sci
. 2024 Oct;
25(20).
PMID: 39456926
Heavy metal pollution is a serious global environmental issue. It threatens human and ecological health. Heavy metals can accumulate in the soil over extended periods and inevitably transfer through the...
7.
Zang S, Wang R, Liu Y, Zhao S, Su L, Dai X, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408770
The agricultural pest exhibits a strong preference for feeding on fresh fruits, demonstrating high adaptability to sugary environments. Meanwhile, high sugar levels stimulate insulin secretion, thereby regulating the steady state...
8.
Wang H, Yang Y, Chen Z, Fu L, Yu M, Jiang L, et al.
Clin Transl Sci
. 2024 Sep;
17(9):e70021.
PMID: 39228016
Olverembatinib (HQP1351) is a BCR-ABL1 tyrosine kinase inhibitor with promising clinical activity. It is approved in China for the treatment of patients with chronic myeloid leukemia harboring drug-resistant mutations, such...
9.
Pan W, Luo Q, Liang E, Shi M, Sun J, Shen H, et al.
Cancer Cell Int
. 2024 May;
24(1):181.
PMID: 38790057
Background: Immune checkpoint inhibitors are approved for the treatment of various tumors, but the response rate is not satisfactory in certain malignancies. Inhibitor of apoptosis proteins (IAP) ubiquitin-E3 ligase activity...
10.
Dai X, Wang Y, Liu Y, Wang R, Su L, Yin Z, et al.
Insects
. 2024 May;
15(5).
PMID: 38786855
The aphidophagous gall midge, (Rondani) (Diptera: Cecidomyiidae), a dominant natural enemy of aphids, has been used as a biological control agent in many countries to control aphids in greenhouses. To...